| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |